Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,160.50    6.00 (0.52%)
Bid:
1,162.50
Ask:
1,163.00
Spread: 0.50 (0.043%)
Market Cap: £9.85b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

24 May 2022 14:30

RNS Number : 6442M
Smith & Nephew Plc
24 May 2022
 

SMITH & NEPHEW PLC

 

24 May 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF A CONDITIONAL AWARD GRANTED UNDER AN AWARD AGREEMENT DATED 29 APRIL 2022

 

On 23 May 2022, the Conditional Award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested over 70,378 Shares. The resultant Shares post-vest were sold on 23 May 2022. Proceeds from the sale of sufficient Shares were utilised to satisfy the taxes due. As previously announced the Conditional Award formed part of buy-out awards in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Vesting of a Conditional Award and subsequent sale of all Shares.

Date of Transaction

2022 - 05 - 23

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

12.743100

70,378 (of which 70,378 were sold and 0 retained)

N/A Single Transaction

0.00000 ordinary shares

0.00000%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

2. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010

 

On 23 May 2022, the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010.

 

i. FINAL VESTING ON 23 MAY 2022 OF CONDITIONAL SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

The awards were granted under the Global Share Plan 2010 on 23 May 2019. One third of the shares vested on 23 May 2020, a further third vested on 23 May 2021 and the final third vested on 23 May 2022. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Final vesting of a Conditional Share Award granted on 23 May 2019 under the Smith & Nephew Global Share Plan 2010.

Date of Transaction

2022 - 05 - 23

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Myra Eskes

(President APAC Region)

PDMR

12.8275

8,571 (of which 0 were sold and 8,571 retained)

N/A Single Transaction

27,183.09703 ordinary shares

0.00307%

 

Simon Fraser

(President, Advanced Wound Management and Global Commercial Operations)

PDMR

12.8275

2,600 (of which 1,027 were sold and 1,573 retained)

N/A Single Transaction

27,398.81838 ordinary shares

0.00310%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFVERISFIF
Date   Source Headline
6th Dec 20247:00 amRNSDirector Share Award vest and sale to cover tax
5th Dec 20243:35 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 20248:43 amRNSHolding(s) in Company
2nd Dec 202411:30 amRNSTotal Voting Rights
12th Nov 20247:00 amRNSDirector/PDMR Shareholding
11th Nov 20244:45 pmRNSDirector/PDMR Shareholding
1st Nov 20243:44 pmRNSDirector/PDMR Shareholding
1st Nov 20242:30 pmRNSTotal Voting Rights
31st Oct 20247:00 amRNSSmith+Nephew Third Quarter 2024 Trading Report
24th Oct 20247:00 amRNSSterling Amount of Dividend
16th Oct 20247:00 amRNSNotice of Results
1st Oct 20243:44 pmRNSTotal Voting Rights
27th Sep 202412:23 pmRNSChange to Directors' Role and Responsibilities
24th Sep 20249:00 amRNSDirector/PDMR Shareholding
19th Sep 20243:50 pmRNSDirector/PDMR Shareholding
17th Sep 20242:27 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:11 pmRNSTotal Voting Rights
30th Aug 202410:38 amRNSDirector/PDMR Shareholding
16th Aug 20249:32 amRNSDirector/PDMR Shareholding
14th Aug 20241:14 pmRNSDirector/PDMR Shareholding
14th Aug 202411:05 amRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSAdoption of Remuneration Policy and RSP
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
5th Aug 202412:08 pmRNSBlock listing Interim Review
1st Aug 202411:09 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSHalf-year Report
12th Jul 20247:00 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSNotice of Results
4th Jul 20247:00 amRNSTR1: Notification of Major Holdings
3rd Jul 20247:00 amRNSTR1: Notification of Major Holdings
1st Jul 20244:22 pmRNSTotal Voting Rights
3rd Jun 20242:03 pmRNSTotal Voting Rights
30th May 20246:17 pmRNSDirector/PDMR Shareholding
24th May 20244:37 pmRNSDirector/PDMR Shareholding
22nd May 20244:23 pmRNSDirector/PDMR Shareholding
21st May 20249:52 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSDividend Declaration
8th May 20247:00 amRNSDirectorate Change
1st May 20244:47 pmRNSResult of AGM
1st May 20241:35 pmRNSTotal Voting Rights
1st May 20247:00 amRNSQ1 2024 Trading Update
23rd Apr 20249:46 amRNSTiming of Smith+Nephew Q1 2024 Trading Report
2nd Apr 20241:43 pmRNSTotal Voting Rights
2nd Apr 20241:19 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSDirectorate Change
14th Mar 20247:00 amRNSSMITH+NEPHEW PRICES USD BOND ISSUE
13th Mar 20244:03 pmRNSDirector/PDMR Shareholding
11th Mar 20246:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.